A citation-based method for searching scientific literature

Laurie H Sehn, Gilles Salles. N Engl J Med 2021
Times Cited: 88



Loretta J Nastoupil, Michael D Jain, Lei Feng, Jay Y Spiegel, Armin Ghobadi, Yi Lin, Saurabh Dahiya, Matthew Lunning, Lazaros Lekakis, Patrick Reagan, Olalekan Oluwole, Joseph McGuirk, Abhinav Deol, Alison R Sehgal, Andre Goy, Brian T Hill, Khoan Vu, Charalambos Andreadis, Javier Munoz, Jason Westin, Julio C Chavez, Amanda Cashen, N Nora Bennani, Aaron P Rapoport, Julie M Vose, David B Miklos, Sattva S Neelapu, Frederick L Locke. J Clin Oncol 2020
Times Cited: 224




List of shared articles



Times cited

Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy.
Roni Shouval, Ana Alarcon Tomas, Joshua A Fein, Jessica R Flynn, Ettai Markovits, Shimrit Mayer, Aishat Olaide Afuye, Anna Alperovich, Theodora Anagnostou, Michal J Besser,[...]. J Clin Oncol 2022
8

Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma.
Michael R Bishop, Michael Dickinson, Duncan Purtill, Pere Barba, Armando Santoro, Nada Hamad, Koji Kato, Anna Sureda, Richard Greil, Catherine Thieblemont,[...]. N Engl J Med 2022
42

Patterns of Use, Outcomes, and Resource Utilization among Recipients of Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed/Refractory Aggressive B Cell Lymphomas.
Peter A Riedell, Wei-Ting Hwang, Loretta J Nastoupil, Martina Pennisi, Joseph P McGuirk, Richard T Maziarz, Veronika Bachanova, Olalekan O Oluwole, Jamie Brower, Oscar A Flores,[...]. Transplant Cell Ther 2022
1


Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma.
Frederick L Locke, David B Miklos, Caron A Jacobson, Miguel-Angel Perales, Marie-José Kersten, Olalekan O Oluwole, Armin Ghobadi, Aaron P Rapoport, Joseph McGuirk, John M Pagel,[...]. N Engl J Med 2022
67

Best Treatment Option for Patients With Refractory Aggressive B-Cell Lymphoma in the CAR-T Cell Era: Real-World Evidence From GELTAMO/GETH Spanish Groups.
Mariana Bastos-Oreiro, Antonio Gutierrez, Juan Luís Reguera, Gloria Iacoboni, Lucía López-Corral, María José Terol, Valentín Ortíz-Maldonado, Jaime Sanz, Luisa Guerra-Dominguez, Rebeca Bailen,[...]. Front Immunol 2022
0

Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: a noncomparative cohort analysis.
Mehdi Hamadani, Ajay K Gopal, Marcelo Pasquini, Soyoung Kim, Xianmiao Qiu, Sairah Ahmed, Aleksandr Lazaryan, Vijaya Raj Bhatt, Andrew Daly, Premal Lulla,[...]. Blood Adv 2022
5

Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell Lymphoma.
Dominic Kaddu-Mulindwa, Philipp Gödel, Nadine Kutsch, Jan-Michel Heger, Christof Scheid, Peter Borchmann, Udo Holtick, Gerhard Held, Lorenz Thurner, Moritz Bewarder,[...]. Clin Lymphoma Myeloma Leuk 2022
0